|

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

RECRUITINGN/ASponsored by Saint Vincent's Hospital, Korea
Actively Recruiting
PhaseN/A
SponsorSaint Vincent's Hospital, Korea
Started2014-07
Est. completion2030-12
Eligibility
Age19 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02920554

Summary

The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group. Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy were enrolled. All patients are randomly assigned to wedge resection or bisegmentectomy group. Number of patients in each group is 44. Primary endpoint is recurrence-free-survival rates and overall survival rates.

Eligibility

Age: 19 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with T2 or T3 gallbladder cancer on preoperative CT exam
* Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy

Exclusion Criteria:

* Peritoneal seeding or distant metastasis
* Impossible to resect the cancer radically
* Pathologically diagnosed to other malignancy such as adenosquamous carcinoma, sarcoma, etc.
* R1 or R2 resection were pathologically diagnosed.

Conditions4

CancerGallbladder CancerLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.